Associated Papers
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Corbett RJ et al.
Nature Communications, 2025
41271695 (PubMed )
Supplement: 41467_2025_65190_MOESM13_ESM.xlsx › germline_snv_indel
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.
Corbett RJ et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
39974082 (PubMed )
Supplement: media-12.xlsx › TableS11A-germline_snv_indel
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
Sievers P et al.
Acta Neuropathologica, 2021
33319313 (PubMed )
Supplement: 401_2020_2247_MOESM2_ESM.pdf
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
Tauziede-Espariat A et al.
Brain Pathology (zurich, Switzerland), 2018
SMARCE1 mutation screening in classification of clear cell meningiomas.
Smith MJ et al.
Histopathology, 2017
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Smith MJ et al.
The Journal of Pathology, 2014
Select a paper to view details